Global Osimertinib Drugs Market Growth 2022-2028
- LP 4891104
- 76 Pages
- March 2022
- Pharmaceuticals
The United States Osimertinib Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Osimertinib Drugs market, reaching US$ million by the year 2028. As for the Europe Osimertinib Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Osimertinib Drugs players cover AstraZeneca, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Osimertinib Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
40mg
80mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drugs Store
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osimertinib Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Osimertinib Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Osimertinib Drugs by Country/Region, 2017, 2022 & 2028
2.2 Osimertinib Drugs Segment by Type
2.2.1 40mg
2.2.2 80mg
2.3 Osimertinib Drugs Sales by Type
2.3.1 Global Osimertinib Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Osimertinib Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Osimertinib Drugs Sale Price by Type (2017-2022)
2.4 Osimertinib Drugs Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.5 Osimertinib Drugs Sales by Application
2.5.1 Global Osimertinib Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Osimertinib Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Osimertinib Drugs Sale Price by Application (2017-2022)
3 Global Osimertinib Drugs by Company
3.1 Global Osimertinib Drugs Breakdown Data by Company
3.1.1 Global Osimertinib Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Osimertinib Drugs Sales Market Share by Company (2020-2022)
3.2 Global Osimertinib Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Osimertinib Drugs Revenue by Company (2020-2022)
3.2.2 Global Osimertinib Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Osimertinib Drugs Sale Price by Company
3.4 Key Manufacturers Osimertinib Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Osimertinib Drugs Product Location Distribution
3.4.2 Players Osimertinib Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Osimertinib Drugs by Geographic Region
4.1 World Historic Osimertinib Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Osimertinib Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Osimertinib Drugs Annual Revenue by Geographic Region
4.2 World Historic Osimertinib Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Osimertinib Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Osimertinib Drugs Annual Revenue by Country/Region
4.3 Americas Osimertinib Drugs Sales Growth
4.4 APAC Osimertinib Drugs Sales Growth
4.5 Europe Osimertinib Drugs Sales Growth
4.6 Middle East & Africa Osimertinib Drugs Sales Growth
5 Americas
5.1 Americas Osimertinib Drugs Sales by Country
5.1.1 Americas Osimertinib Drugs Sales by Country (2017-2022)
5.1.2 Americas Osimertinib Drugs Revenue by Country (2017-2022)
5.2 Americas Osimertinib Drugs Sales by Type
5.3 Americas Osimertinib Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Osimertinib Drugs Sales by Region
6.1.1 APAC Osimertinib Drugs Sales by Region (2017-2022)
6.1.2 APAC Osimertinib Drugs Revenue by Region (2017-2022)
6.2 APAC Osimertinib Drugs Sales by Type
6.3 APAC Osimertinib Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Osimertinib Drugs by Country
7.1.1 Europe Osimertinib Drugs Sales by Country (2017-2022)
7.1.2 Europe Osimertinib Drugs Revenue by Country (2017-2022)
7.2 Europe Osimertinib Drugs Sales by Type
7.3 Europe Osimertinib Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Osimertinib Drugs by Country
8.1.1 Middle East & Africa Osimertinib Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Osimertinib Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Osimertinib Drugs Sales by Type
8.3 Middle East & Africa Osimertinib Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Osimertinib Drugs
10.3 Manufacturing Process Analysis of Osimertinib Drugs
10.4 Industry Chain Structure of Osimertinib Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Osimertinib Drugs Distributors
11.3 Osimertinib Drugs Customer
12 World Forecast Review for Osimertinib Drugs by Geographic Region
12.1 Global Osimertinib Drugs Market Size Forecast by Region
12.1.1 Global Osimertinib Drugs Forecast by Region (2023-2028)
12.1.2 Global Osimertinib Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Osimertinib Drugs Forecast by Type
12.7 Global Osimertinib Drugs Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Osimertinib Drugs Product Offered
13.1.3 AstraZeneca Osimertinib Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
14 Research Findings and Conclusion
Table 1. Osimertinib Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Osimertinib Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 40mg
Table 4. Major Players of 80mg
Table 5. Global Osimertinib Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Osimertinib Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Osimertinib Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Osimertinib Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Osimertinib Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Osimertinib Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Osimertinib Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Osimertinib Drugs Revenue by Application (2017-2022)
Table 13. Global Osimertinib Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Osimertinib Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Osimertinib Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Osimertinib Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Osimertinib Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Osimertinib Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Osimertinib Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Osimertinib Drugs Producing Area Distribution and Sales Area
Table 21. Players Osimertinib Drugs Products Offered
Table 22. Osimertinib Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Osimertinib Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Osimertinib Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Osimertinib Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Osimertinib Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Osimertinib Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Osimertinib Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Osimertinib Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Osimertinib Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Osimertinib Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Osimertinib Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Osimertinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Osimertinib Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Osimertinib Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Osimertinib Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Osimertinib Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Osimertinib Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Osimertinib Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Osimertinib Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Osimertinib Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Osimertinib Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Osimertinib Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Osimertinib Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Osimertinib Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Osimertinib Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Osimertinib Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Osimertinib Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Osimertinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Osimertinib Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Osimertinib Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Osimertinib Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Osimertinib Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Osimertinib Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Osimertinib Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Osimertinib Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Osimertinib Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Osimertinib Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Osimertinib Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Osimertinib Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Osimertinib Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Osimertinib Drugs
Table 66. Key Market Challenges & Risks of Osimertinib Drugs
Table 67. Key Industry Trends of Osimertinib Drugs
Table 68. Osimertinib Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Osimertinib Drugs Distributors List
Table 71. Osimertinib Drugs Customer List
Table 72. Global Osimertinib Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Osimertinib Drugs Sales Market Forecast by Region
Table 74. Global Osimertinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Osimertinib Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Osimertinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Osimertinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Osimertinib Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Osimertinib Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Osimertinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Osimertinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Osimertinib Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Osimertinib Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Osimertinib Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Osimertinib Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Osimertinib Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Osimertinib Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Osimertinib Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Osimertinib Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Osimertinib Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Osimertinib Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. AstraZeneca Basic Information, Osimertinib Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Osimertinib Drugs Product Offered
Table 94. AstraZeneca Osimertinib Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
List of Figures
Figure 1. Picture of Osimertinib Drugs
Figure 2. Osimertinib Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Osimertinib Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Osimertinib Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Osimertinib Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 40mg
Figure 10. Product Picture of 80mg
Figure 11. Global Osimertinib Drugs Sales Market Share by Type in 2021
Figure 12. Global Osimertinib Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Osimertinib Drugs Consumed in Hospital
Figure 14. Global Osimertinib Drugs Market: Hospital (2017-2022) & (K Units)
Figure 15. Osimertinib Drugs Consumed in Drugs Store
Figure 16. Global Osimertinib Drugs Market: Drugs Store (2017-2022) & (K Units)
Figure 17. Global Osimertinib Drugs Sales Market Share by Application (2017-2022)
Figure 18. Global Osimertinib Drugs Revenue Market Share by Application in 2021
Figure 19. Osimertinib Drugs Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Osimertinib Drugs Revenue Market Share by Company in 2021
Figure 21. Global Osimertinib Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Osimertinib Drugs Revenue Market Share by Geographic Region in 2021
Figure 23. Global Osimertinib Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global Osimertinib Drugs Revenue Market Share by Country/Region in 2021
Figure 25. Americas Osimertinib Drugs Sales 2017-2022 (K Units)
Figure 26. Americas Osimertinib Drugs Revenue 2017-2022 ($ Millions)
Figure 27. APAC Osimertinib Drugs Sales 2017-2022 (K Units)
Figure 28. APAC Osimertinib Drugs Revenue 2017-2022 ($ Millions)
Figure 29. Europe Osimertinib Drugs Sales 2017-2022 (K Units)
Figure 30. Europe Osimertinib Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Osimertinib Drugs Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Osimertinib Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Americas Osimertinib Drugs Sales Market Share by Country in 2021
Figure 34. Americas Osimertinib Drugs Revenue Market Share by Country in 2021
Figure 35. United States Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Osimertinib Drugs Sales Market Share by Region in 2021
Figure 40. APAC Osimertinib Drugs Revenue Market Share by Regions in 2021
Figure 41. China Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Osimertinib Drugs Sales Market Share by Country in 2021
Figure 48. Europe Osimertinib Drugs Revenue Market Share by Country in 2021
Figure 49. Germany Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Osimertinib Drugs Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Osimertinib Drugs Revenue Market Share by Country in 2021
Figure 56. Egypt Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Osimertinib Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Osimertinib Drugs in 2021
Figure 62. Manufacturing Process Analysis of Osimertinib Drugs
Figure 63. Industry Chain Structure of Osimertinib Drugs
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
